Production of critical cytokines by T-cells and other host cells, especially monocytes, mediates resistance and susceptibility to infectious agents. We are testing two doses of the drug thalidomide in a placebo-controlled clinical trial in patients with HIV associated wasting. We hope to reduce the production of TNFa and thereby reduce wasting, fevers and the production of the virus.
Showing the most recent 10 out of 461 publications